Alain Schreiber, 10% Owner at CADENCE PHARMACEUTICALS INC (CADX), sold 57,400 shares at $14.44 ($830K) on 2007-08-31, disclosed to the SEC on 2007-09-04.
Open-market sale of $830k CADX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.36 | 5,800 | $83K | 10.0% |
| 2 | $14.36 | 832 | $12K | 1.4% |
| 3 | $14.37 | 700 | $10K | 1.2% |
| 4 | $14.38 | 1,200 | $17K | 2.1% |
| 5 | $14.38 | 100 | $1K | 0.2% |
| 6 | $14.39 | 1,200 |
| $17K |
| 2.1% |
| 7 | $14.40 | 3,068 | $44K | 5.3% |
| 8 | $14.40 | 2,000 | $29K | 3.5% |
| 9 | $14.42 | 16,900 | $244K | 29.3% |
| 10 | $14.43 | 5,000 | $72K | 8.7% |
| 11 | $14.43 | 200 | $3K | 0.3% |
| 12 | $14.44 | 200 | $3K | 0.3% |
| 13 | $14.45 | 1,400 | $20K | 2.4% |
| 14 | $14.48 | 5,400 | $78K | 9.4% |
| 15 | $14.49 | 2,600 | $38K | 4.5% |
| 16 | $14.50 | 300 | $4K | 0.5% |
| 17 | $14.57 | 700 | $10K | 1.2% |
| 18 | $14.58 | 100 | $1K | 0.2% |
| 19 | $14.61 | 100 | $1K | 0.2% |
| 20 | $14.63 | 100 | $1K | 0.2% |
| 21 | $14.64 | 800 | $12K | 1.4% |
| 22 | $14.65 | 100 | $1K | 0.2% |
| 23 | $14.66 | 2,900 | $43K | 5.1% |
| 24 | $14.67 | 400 | $6K | 0.7% |
| 25 | $14.68 | 200 | $3K | 0.4% |
| 26 | $14.69 | 500 | $7K | 0.9% |
| 27 | $14.70 | 100 | $1K | 0.2% |
| 28 | $14.71 | 2,300 | $34K | 4.1% |
| 29 | $14.72 | 1,800 | $26K | 3.2% |
| 30 | $14.73 | 400 | $6K | 0.7% |
| Total | $14.47 avg | 57,400 | $830K | 100% |
| Filing → |
| IMDZ | SELL | 2015-04-16 | $1.5M | — | Filing → |
| IMDZ | SELL | 2015-03-12 | $3.2M | — | Filing → |
| EGRX | BUY | 2014-02-20 | $5.0M | — | Filing → |